Wenyong Chen
- Molecular Biology top 5%
- Geriatrics and Gerontology top 0.2%
- Epidemiology top 5%
- Oncology top 5%
- Hematology top 2%
- Co-authors
- Stephen B. BaylinMichael RothTim M. TownesHongfeng YuanRavi BhatiaWei GuRay-Whay Chiu YenDavid H. Wang
- Topics
- Chronic Myeloid Leukemia Treatments (14 papers)Sirtuins and Resveratrol in Medicine (11 papers)Histone Deacetylase Inhibitors Research (9 papers)
- Journals
- CellProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Wenyong Chen
60 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 2.1k
- Geriatrics and Gerontology 989
- Epidemiology 781
- Oncology 709
- Hematology 386
Countries citing papers authored by Wenyong Chen
This map shows the geographic impact of Wenyong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyong Chen more than expected).
Fields of papers citing papers by Wenyong Chen
This network shows the impact of papers produced by Wenyong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyong Chen. The network helps show where Wenyong Chen may publish in the future.
Co-authorship network of co-authors of Wenyong Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Wenyong Chen. A scholar is included among the top collaborators of Wenyong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyong Chen. Wenyong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 6 | |
| 3 | 15 | |
| 4 | 6 | |
| 5 | 8 | |
| 6 | 2 | |
| 7 | 34 | |
| 8 | 1 | |
| 9 | 72 | |
| 10 | 27 | |
| 11 | 23 | |
| 12 | 59 | |
| 13 | 327 | |
| 14 | 87 | |
| 15 | 201 | |
| 16 | 41 | |
| 17 | Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responsesbreakdown → | 530 |
| 18 | 130 | |
| 19 | 14 | |
| 20 | 19 |
About Wenyong Chen
Wenyong Chen is a scholar working on Geriatrics and Gerontology, Hematology and Genetics, having authored 65 papers that have together received 3.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (14 papers), Sirtuins and Resveratrol in Medicine (11 papers) and Histone Deacetylase Inhibitors Research (9 papers). The work is most often cited by research in Geriatrics and Gerontology (989 citations), Physiology (233 citations) and Hematology (386 citations). Wenyong Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Stephen B. Baylin, Michael Roth, Tim M. Townes, Hongfeng Yuan, Ravi Bhatia, Wei Gu, Ray-Whay Chiu Yen, David H. Wang, Jianyuan Luo and Zhiqiang Wang. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.